ATB Capital Issues Pessimistic Forecast for Aurora Cannabis (TSE:ACB) Stock Price

Aurora Cannabis (TSE:ACB) had its price objective trimmed by ATB Capital from C$11.00 to C$8.50 in a report issued on Tuesday,BayStreet.CA reports.

Separately, TD Securities upgraded Aurora Cannabis to a “strong-buy” rating in a research note on Thursday, December 12th. Three research analysts have rated the stock with a hold rating, one has assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of C$5.85.

Aurora Cannabis Trading Down 3.8 %

Shares of ACB stock opened at C$5.88 on Tuesday. Aurora Cannabis has a 12-month low of C$3.84 and a 12-month high of C$12.85. The firm has a 50 day moving average price of C$6.89 and a two-hundred day moving average price of C$7.56. The company has a quick ratio of 2.48, a current ratio of 3.76 and a debt-to-equity ratio of 16.95. The company has a market capitalization of C$321.40 million, a PE ratio of -9.33 and a beta of 2.71.

Insiders Place Their Bets

In other news, Senior Officer Andre Jerome sold 7,712 shares of the stock in a transaction on Monday, September 23rd. The stock was sold at an average price of C$7.70, for a total transaction of C$59,382.40.

About Aurora Cannabis

Aurora Cannabis Inc, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers medical and consumer cannabis products; supplies propagated vegetables and ornamental plants; and distributes and sells hemp-derived cannabidiol (CBD) products.